右旋布洛芬缓释胶囊在比格犬体内的药物动力学Evaluation of the pharmacokinetics of dexibuprofen modified-release capsules in Beagle dog
宫爱申,徐静华,张逸凡,钟大放
GONG Ai-shen 1; XU Jing-hua 2; ZHANG Yi-fan 1; ZHONG Da-fang 1 (1. Laboratory of Drug Metabolism and Pharmacokinetics;
摘要(Abstract)：
目的建立一种快速、专属的HPLC UV法用于测定比格犬血浆中右旋布洛芬的浓度 ,应用本法对右旋布洛芬缓释胶囊在比格犬体内的药物动力学行为进行研究。方法 8只比格犬采用双周期交叉试验设计 ,分别口服给予右旋布洛芬缓释胶囊 (受试制剂 )及清芬片 (右旋布洛芬片 ,参比制剂 )后按时间点采集血样进行分析 ,绘制血药质量浓度 时间曲线 ,计算相关药动学参数。结果经统计分析 ,两种制剂间药动学参数AUC0 -t、AUC0 -∞ 无显著性差异 ,受试制剂峰质量浓度 ρmax低于参比制剂 ,tmax显著增大。结论受试制剂右旋布洛芬缓释胶囊具备了一定的缓释特征
Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma,and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma.Method A single dose,two periods,cross-over study in 8 Beagle dogs was carried out.After an oral dose of dexibuprofen modified-release capsules (test) or Qingfen tablets (reference),the plasma samples were drawn and analyzed.Results There were no significant difference in AUC 0-t and AUC 0-∞ between the two preparations,but ρ max of the test preparation was less than the reference one and t max was obviously larger than it.Conclusion The release of the test preparation dexibuprofen modified-release capsules is modified.
关键词(KeyWords)：
右旋布洛芬;药物动力学;缓释胶囊
dexibuprofen; pharmacokinetics; modified-release capsules
基金项目(Foundation): 国家自然科学基金资助项目 (39930 180 )
作者(Authors):
宫爱申,徐静华,张逸凡,钟大放
GONG Ai-shen 1; XU Jing-hua 2; ZHANG Yi-fan 1; ZHONG Da-fang 1 (1. Laboratory of Drug Metabolism and Pharmacokinetics;
参考文献(References)：
- [1]GabardB ,NirnbergerG .Comparisonofthebioavail abilityofdexibuprofenadministeredaloneoraspartofracemicibuprofen[J].EurJClinPharmacol,1995,48:505-511.
- [2]SingerF ,MayrhoferF ,KleinG ,etal.Evaluationoftheefficacyanddose responserelationshipofdex ibuprofen(S (+) ibuprofen)in patientswithos teoarthritisofthehipandcomparisonwithracemicibuprofenusingtheWOMACosteoarthritisindex[J].IntJClinPharmacolTher,2000,38(1):15-24.
- [3]GeisslingerG ,StockKP ,BachGL ,etal.Pharmacolog icaldifferencesbetweenR(-) andS(+) ibuprofen[J].AgentsActions,1989,27(3-4):455-457.
- [4]成立军,赵志春.反相高效液相色谱法测定血浆中布洛芬浓度[J].中国临床药学杂志,2002,11(3):173-175.
- [5]SochorJ ,KlimesJ ,SedlacekJ ,etal.Determinationofibuprofeninerythrocytesand plasmabyhigh perfor manceliquidchromatography[J].JPharmBiomedAnal,1995,13(7):899-903.
- [6]CorpettiG ,RosignoliMT ,DionisioP .Comparativebioavilabilitystudyoftwooralformulationofibuprofen[J].Arzenim forschung,1998,48(4):392-395.
- [7]国家药品监督管理局.化学药品临床前药代动力学研究指导原则(试行)[M ].北京:中国医药科技出版社,2002.
- [8]RogerC .Validationofchromatographicmethodsinbiomedicalanalysisviewpointanddiscussion[J].JChromatogrB ,1997,689:175-180.
- [9]FrihmatR ,CardotJM ,BoucherM ,etal.Bioinversionofibuprofenenatiomersafteradministrationindogs:estimationofanovelindex[J].EurJDrugMetabPharmacokinet,2000,25:205-211.
- [10]AibaT ,TseMM ,LinET ,etal.Effectofdosageformonstereoisomericinversionofibuprofeninvolunteers[J].BioPharmBull,1999,22:616-622.
- [11]RomeroAJ,RackleyRJ,RhodesCT .Anevaluationofibuprofenbioinversionbysimulation[J].Chirality,1991,3:418-421.